FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/12/030112 [Registered on: 29/12/2020] Trial Registered Prospectively
Last Modified On: 28/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Prospective observational 
Study Design  Single Arm Study 
Public Title of Study   A study done to compare the accuracy of one technique over pulse oximetry to detect a drop in oxygen level in the blood. 
Scientific Title of Study   An observational study to determine the accuracy of Oxygen Reserve Index (Ori) to predict impending desaturation in patient’s undergoing procedures under apnoea. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
3553_version_2.0_dated_16.10.2020  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Jeson R Doctor 
Designation  Professor 
Affiliation  Tata Memorial Hospital Mumbai 
Address  Room No 210, Department of Anaesthesia, Critical Care and Pain, 2nd floor, Main building, Tata Memorial Hospital, Dr E Borges Marg, Parel,

Mumbai
MAHARASHTRA
400012
India 
Phone  09820054956  
Fax  02224146937  
Email  jesonrdoctor@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jeson R Doctor 
Designation  Professor 
Affiliation  Tata Memorial Hospital Mumbai 
Address  Room No 210, Department of Anaesthesia, Critical Care and Pain, 2nd floor, Main building, Tata Memorial Hospital, Dr E Borges Marg, Parel,

Mumbai
MAHARASHTRA
400012
India 
Phone  09820054956  
Fax  02224146937  
Email  jesonrdoctor@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Urmila Phad 
Designation  PG Student 
Affiliation  Tata Memorial Hospital Mumbai 
Address  Room No 210, Department of Anaesthesia, Critical Care and Pain, 2nd floor, Main building, Tata Memorial Hospital, Dr E Borges Marg, Parel,

Mumbai
MAHARASHTRA
400012
India 
Phone  09763926368  
Fax  02224146937  
Email  phadurmila1@gmail.com  
 
Source of Monetary or Material Support  
Tata Memorial Hospital Dr E Borges Marg, Parel, Mumbai 400012, Maharashtra, India 
 
Primary Sponsor  
Name  Dr Jeson R Doctor 
Address  Room No 210, Department of Anaesthesia, Critical Care and Pain, 2nd floor, Main building, Tata Memorial Hospital, Dr E Borges Marg, Parel, Mumbai 400012 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Dr Sohan Solanki  Room No 210, Department of Anaesthesia, Critical Care and Pain, 2nd floor, Main building, Tata Memorial Hospital, Dr E Borges Marg, Parel,Mumbai 400012 
Dr Urmila Phad  Room No 210, Department of Anaesthesia, Critical Care and Pain, 2nd floor, Main building, Tata Memorial Hospital, Dr E Borges Marg, Parel, Mumbai 400012 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jeson R Doctor  Tata Memorial Hospital  Room No 210, Department of Anaesthesia, Critical Care and Pain, 2nd floor, Main building, Tata Memorial Hospital, Dr E Borges Marg, Parel,Mumbai 400012
Mumbai
MAHARASHTRA 
09820054956
02224146937
jesonrdoctor@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Tata Memorial Hospital Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C00-C14||Malignant neoplasms of lip, oral cavity and pharynx, (2) ICD-10 Condition: C30-C39||Malignant neoplasms of respiratory and intrathoracic organs,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Adults 18 - 80 years’ old
2. American Society of Anesthesiologists (ASA) physical status classification system:1 or 2
3. Any patient undergoing any procedure under general anaesthesia with apnoea and apnoeic oxygenation. e.g. direct laryngoscopic/ microlaryngoscopic evaluation or laser surgery for head and neck cancer, tracheal dilatation or stenting done under apnoeic oxygenation.
 
 
ExclusionCriteria 
Details  1. Any patients with respiratory ailments (e.g. chronic obstructive pulmonary disease, asthma) or poor pulmonary function- Objective parameter to identify poor effort tolerance is ability to climb less than 1 flight of stairs.
2. Patients with baseline saturation less than 95% on room air.
3. Expected difficulty in tracheal intubation due to insufficient mouth opening and trismus where an awake fibreoptic intubation is planned.
4. Patients with stridor or an obstructed airway.
5. Patients with nail polish or Henna on fingers and nails- in whom the pulse oximeter readings may not be accurate.
6. No informed consent
7. Inability to wear the sensor due to deformity or hypoperfusion of the fingers
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To find out the time lag between the ORI alarm at 0.24 and Sp02 to drop to 95%.
 
The corresponding SpO2 and ORI values will be recorded every 5 seconds for 3 minutes. In case the ORI and SpO2 does not drop in 3 minutes the time at which ORI drops to 0.24 and Spo2 drops to 95% will be noted from the time of apnoea. The time interval between the ORI alarm and the fall in SpO2 to 95% will also be recorded.
 
 
Secondary Outcome  
Outcome  TimePoints 
Time taken, for the ORI to rise up to 0.24 and the SpO2 to rise to 100% after resuming ventilation and the time difference between the two.  Oxygenation with anaesthesia breathing circuit will be resumed once the patient starts desaturating to less than 95%. The time taken for the ORI to rise back to 0.24 and SpO2 to rise to 100% after reoxygenation will also be noted in seconds from the time of resuming of ventilation of the patient. 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "39"
Final Enrollment numbers achieved (India)="39" 
Phase of Trial   N/A 
Date of First Enrollment (India)   09/01/2021 
Date of Study Completion (India) 17/04/2023 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

INTRODUCTION AND BACKGROUND-

Pulse oximetry provides continuous, non-invasive assessment of arterial oxygen saturation and is a sensitive detector of hypoxemia and major hypoxic events. With a pulse oximeter we monitor the peripheral arterial oxygen saturation (SpO2). The shape of the oxygen dissociation curve is sigmoidal showing that the relationship between arterial partial pressure of oxygen (PaO2) and arterial oxygen saturation (SaO2) is not linear. Once the decline of PaO2 passes the inflection point of the oxygen-haemoglobin dissociation curve, the SpO2 decreases rapidly with the decline of PaO2. This means that there is a rapid SaO2 and SpO2 decline once PaO2 decreases to <80 mm Hg. A SpO2 of 95% corresponds to a PaO2 of 80 mm of Hg and a SpO2 of 90% corresponds to a PO2 of 60 mm of Hg. Above a PaO2 80 mm of Hg the SpO2 will always read as 98-100%. Thus, SpO2 may not provide advance warning of falling arterial oxygenation until PaO2 approaches this level.  It is difficult to predict when desaturation will start in apnoeic patients.

The Oxygen Reserve Index (ORI) is a relatively new technology by Masimo InternationalTM (1-3) It is a non-invasive and continuous parameter intended to provide insight into the patient’s oxygen reserve in the moderate hyperoxic range i.e. between PaO2 of 100 and 200 mm of Hg. Itis a nondimensional index that ranges from 0 to 1. It is measured by optically detecting changes in venous oxygen saturation (SvO2) after arterial oxygen saturation (SaO2) saturates to the maximum. Applegate et al(1) showed a positive linear relationship for PaO2 up to 240 mm Hg and ORI using linear regression analysis (r2 = 0.536). When ORI was over 0.24, all measured PaO2 were ≥100 mm Hg and SaOwas 100%. When ORI was over 0.55, they found that 96.6% of PaO2 measurements were ≥150 mm Hg. ORI decrease to 0.24 provides advance warning of PaO2 declining to approximately 100 mm Hg when SpO2 is>98%.ORI could indicate PaO2 decreases before SpO2 falls providing advance warning of impending desaturation events. ORI is an index that is intended to supplement, not replace SaO2, SpO2 and PaO2 measurements.

In a study done in children by Szmuk et al they found that ORI detected impending desaturation in median of 31.5 s (interquartile range, 19–34.3 s) before noticeable changes in SpO2 occurred.(3) This represents a clinically important warning time, which might give clinicians time for corrective actions.

Head and neck malignancies require direct laryngoscopic evaluation for disease mapping. Some patients may require microlaryngoscopic evaluation and laser surgery. Similarly, some thoracic procedures like tracheal dilatation or stenting are done in the interventional radiology suite. These procedures are done under general anaesthesia with muscle relaxant and apnoeic oxygenation to have immobile vocal cords for evaluation, biopsy and laser surgery.

During this evaluation a lower limit of 95% SpO2 is taken as a warning as patients start rapidly desaturating below that. Reoxygenation or mask ventilation is done once the patient SpO2 drops below 90%on pulse oximetry. The purpose of using ORI in these cases in addition to a pulse oximeter is to reliably predict the impending hypoxia once the ORI starts dropping before the patient starts desaturating on the pulse oximeter.

 HYPOTHESIS AND AIMS-

We hypothesise that ORI may help us in predicting impending desaturation on pulse oximetry and hypoxia during patients undergoing procedures under apnoeic oxygenation. 

The aim of our study is to estimate the accuracy of ORI in predicting impending desaturation and hypoxia during patients undergoing procedures under apnoeic oxygenation.

 STUDY DESIGN AND METHODOLOGY-

Study design- Prospective observational study

Site- TMH

Population:

Inclusion Criteria:

1.      Adults 18 - 80 years’ old

2.      American Society of Anesthesiologists (ASA) physical status classification system:1 or 2

3.      Any patient undergoing any procedure under general anaesthesia with apnoea and apnoeic oxygenation. e.g. direct laryngoscopic/ microlaryngoscopic evaluation or laser surgery for head and neck cancer, tracheal dilatation or stenting done under apnoeic oxygenation.

Exclusion Criteria:

1.      Any patients with respiratory ailments (e.g. chronic obstructive pulmonary disease, asthma) or poor pulmonary function- Objective parameter to identify poor effort tolerance is ability to climb less than 1 flight of stairs.

2.      Patients with baseline saturation less than 95% on room air.

3.      Expected difficulty in tracheal intubation due to insufficient mouth opening and trismus where an awake fibreoptic intubation is planned.

4.      Patients with stridor or an obstructed airway.

5.      Patients with nail polish or Henna on fingers and nails- in whom the pulse oximeter readings may not be accurate.

6.      No informed consent

7.      Inability to wear the sensor due to deformity or hypoperfusion of the fingers

 

This study will be initiated after approval from the institutional ethics committee and registration with CTRI. Adult patients between 18-80 years of age posted for elective surgery other than those meeting exclusion criteria and requiring general anaesthesia with apnoea will be included in this prospective observational study. Consent for the participation in the study will be taken from all eligible patients. Patients will be taken to the operating room and the monitors will be attached. The monitoring will include electrocardiography, pulse oximeter, non-invasive blood pressure and ORI probe from MasimoTM monitor. After doing the surgical safety checklist, IV access will be secured. The pulse oximeter probe and the ORI monitor probe of the MasimoTM monitor will be put on separate fingers on the same hand. The non-invasive blood pressure cuff will be attached on the opposite arm so that the measurements do not lead to loss of the pulse oximeter signal and plethysmograph. The patient will be preoxygenated with 100% oxygen for 3 minutes. The corresponding SpO2 and ORI values will be noted. Induction of general anaesthesia will be done as per the discretion of the attending anaesthesia consultant. After the patient is apnoeic following administration of a muscle relaxant apnoeic oxygenation with nasal prongs and 15 litres of oxygen will be started. The corresponding time of apnoea will be noted. The surgeon will be allowed to proceed with the procedure which may include direct laryngoscopic or microlaryngoscopic mapping of the disease or laser surgery. The corresponding SpO2 and ORI values will be recorded every 5 seconds for 3 minutes. In case the ORI and SpO2 does not drop in 3 minutes the time at which ORI drops to 0.24 and Spo2 drops to 95% will be noted from the time of apnoea. The time interval between the ORI alarm and the fall in SpO2 to 95% will also be recorded. Oxygenation with anaesthesia breathing circuit will be resumed once the patient starts desaturating to less than 95%. The time taken for the ORI to rise back to 0.24 and SpO2 to rise to 100% after reoxygenation will also be noted in seconds from the time of resuming of ventilation of the patient.

The current standard of care for patients undergoing procedures with apnoeic oxygenation technique is recognition of desaturation using a pulse oximeter. When the SpO2 falls to 95% the surgeon is informed the need to reoxygenate the patient. If the procedure is likely to take more time the reoxygenation is started once the SpO2 drops below 90%.

The additional intervention in our study is only recording ORI values using an ORI probe. Since ORI is still being evaluated, ORI readings will not be used to decide patient management. The management of these patients will continue to be done based on oxygen saturation which is the current standard of care.

Objectives of the study-

Primary objective: -

To find out the time lag between the ORI alarm at 0.24 and Sp02 to drop to 95%.

Secondary Objective-

 Time taken, for the ORI to rise up to 0.24 and the SpO2 to rise to 100% after resuming ventilation and the time difference between the two.

Sample size and statistical analysis-

Sample size justification-

The primary objective is to calculate mean time between ORI 0.24 and SaO2 95%. Assuming that this is average 35 seconds(3) and 5 sec standard deviation, a sample size of 25 is required to produce a two-sided 95% confidence interval with a distance from the mean to the limits which is equal to 2 sec.

 

The primary objective is to calculate mean time difference between ORI decreasing to 0.24 and SaO2 decreasing to 95%. Assuming a 5 sec standard deviation, a sample size of 28 is required to find the true mean difference with a margin of error of 2 seconds with 95% confidence. This means that if we study 28 patients and find that the mean time difference between ORI 0.24 and SaO2 of 95% is x seconds, we can be 95% sure that in the population, the mean time difference between ORI 0.24 and SaO2 of 95% will lie between x-2 and x+2 seconds. 

Since the duration of surgical procedures and physiological status of patients is variable, some patients may not desaturate to 95% during the procedure (procedure may be completed before the end-point is reached) - such patients will not be analyzable for the primary outcome. Therefore, we plan to accrue 50 patients to have analyzable data in 28 patients.

Since this is a thesis project, we will analyse whatever cases we accrue at the end of Nov 2021. The study will however continue till we complete accrual of 28 analyzable patients.

Statistical Analysis Plan: -

Data will be descriptively analysed using mean and standard deviation for continuous variables and frequency and percentage for categorical variables.

The time that elapses between activation of the oxygen Reserve alarm until saturation reached 95% without ventilation, that is, the warning time the index provides of impending desaturation will be calculated as the mean time in seconds and the standard deviation will be reported depending on the normality of the data. We will report 95% confidence intervals for this estimate

We will also report the means of the time (with 95% CI) for ORI to recover to 0.24, for SaO2 to recover to 100% and the difference between the two.

 

 
Close